• Martone will assist with evaluating and sourcing U.S. and Canadian sites, focusing on power availability, connectivity, and operational feasibility.
• The move reflects SolarBank’s strategy to align with AI-driven data demand and to integrate clean energy solutions with digital infrastructure.
• The company has reaffirmed its U.S. focus to reduce exposure to tariffs on imports from China, Mexico, and Canada.
• SolarBank’s recent $49.8 million deal with Qcells underpins its commitment to “Made in America” infrastructure.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has taken a key step in advancing its expansion into the data center market by bringing on seasoned advisor Jonathan Martone. The company announced it has retained Martone and his firm, Martone Advisors LLC, to support strategic efforts in identifying and assessing opportunities for data center development in North America (https://ibn.fm/mytyQ).

Martone, who has spent over 25 years in the telecommunications and data center sectors, is known for his hands-on role in building data center ecosystems and advising clients on network design and site development. His background includes consulting for private equity firms and operators to evaluate sites for both build-to-suit and multi-tenant facilities, with a focus on energy infrastructure, fiber connectivity, and interconnection strategies.

SolarBank announced plans to expand into the data center space in November 2024. The hiring of Martone signals a deepening commitment to the sector, especially as artificial intelligence, cloud computing, and high-performance workloads continue to drive demand for hyperscale and edge facilities.

Dr. Richard Lu, CEO of SolarBank, emphasized Martone’s practical knowledge and network, underlining that his appointment will bring significant value to the company. “Jonathan has significant contacts and is one of the leaders in North America in understanding site selection and the components to ensure a successful operation. The growth of data-hungry artificial intelligence deployments continues, and SolarBank is seeking to help support this demand,” Dr. Lu added.

Martone’s scope will include evaluating SolarBank’s current pipeline of potential projects in the United States and Canada. According to the company, these markets offer both energy infrastructure reliability and a lower-risk regulatory environment—particularly relevant in light of recent U.S. tariff actions targeting imports from foreign countries.

“SolarBank has always been focused on the development of projects in the United States that provide clean energy to support communities,” Dr. Lu stated in a recent press release (https://ibn.fm/46U8x). “The recently announced tariffs on Canada, Mexico and China are not expected to have an impact on our business. In particular, our recently announced $49.8 million transaction with Qcells will see four projects developed with ‘Made in America’ solar panels.”

That transaction, announced earlier this year, not only supports domestic manufacturing but also helps shield SolarBank from global supply chain risks and potential cost increases associated with trade policy shifts. “SolarBank believes it can navigate supply chain issues to continue to develop projects with positive economics,” Dr. Lu said. There is still uncertainty on the overall impact of tariffs on SolarBank’s operations and the global economy, but sourcing made in America panels helps SolarBank to mitigate these risks.

Martone’s role will go beyond site identification. He is also expected to advise on utility planning, power availability, and the integration of clean energy sources—a fit for SolarBank’s existing business model. His client history includes work with EdgeConneX, Overwatch Capital, and Form8tion Data Centers, among others, covering areas from fiber connectivity to hyperscale deployments.

He brings technical understanding of complex power systems, including medium and high-voltage design, transformer capacity, and interconnection fabrics tailored for enterprise and public-sector workloads. These areas are critical as SolarBank aims to link clean energy assets with data infrastructure that is both scalable and efficient.

For SolarBank, the expansion into data centers represents a logical evolution of its renewable energy expertise. With the digital sector increasingly pressured to decarbonize, the intersection between power generation and data hosting is becoming a growing area of interest for investors.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “Data Center Expert Jonathan Martone Retained by SolarBank Corporation to Power Strategic Expansion” for additional details on the statements and related assumptions and risks.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• ESGold has completed data acquisition for a deep subsurface imaging survey at its Montauban Project in Quebec.
• The Ambient Noise Tomography (“ANT”) survey revealed imaging depths of over 800 meters—double the original plan.
• A 3D model integrating ANT data and historical information is in development to guide future drilling.
• The survey marks the first deep-sensing exploration campaign at Montauban, a fully permitted pre-production site.
• The company intends to begin production at Montauban in Q3 2025.
• Production is set to begin in the third quarter of 2025, with an initial throughput capacity of 500 tonnes per day, scalable to 1,000 tonnes.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, has completed a major step in advancing its Montauban Project in Quebec with the conclusion of a subsurface imaging survey that could redefine the geological scale of the site (https://ibn.fm/3Q3TY).

The company announced completion of the Ambient Noise Tomography (“ANT”) survey, conducted by Caur Technologies over a 10 km² grid. The geophysical work, which began in March 2025, is now in the processing and interpretation stage, with results expected before the end of April 2025. The imaging results will be used to build a comprehensive 3D model of the Montauban subsurface—its first ever.

Originally intended to reach depths of 400 meters, the ANT survey exceeded expectations. The geophones, which are up to ten times more sensitive than standard nodal equipment, captured data beyond 800 meters. This new depth range opens the door to identifying previously hidden mineralized zones and refining the project’s exploration targets.

Located roughly 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine. ESGold has invested more than C$15 million in infrastructure, including roads, power lines, and a 16,000-square-foot processing facility. Production is set to begin in the third quarter of 2025, with an initial throughput capacity of 500 tonnes per day, scalable to 1,000 tonnes.

ESGold believes Montauban may share geological similarities with Australia’s Broken Hill deposit, which has produced over $100 billion in metals. Both systems are polymetallic and structurally complex, traits that make deeper imaging especially relevant for uncovering additional mineral zones.

The collected data will be combined with geological mapping, previous drill results, and geochemical datasets to refine the site’s geological model. The integrated interpretation is expected to enhance ESGold’s ability to prioritize drill targets and reduce exploration risk going forward. This initiative also aligns with ESGold’s strategy to self-finance exploration by reprocessing the site’s historical tailings—over 900,000 tonnes in total. Revenue from early-stage operations will help fund ongoing exploration across Montauban’s district-scale land package.

Brad Kitchen, President of ESGold, said the ANT survey was a critical step forward in the company’s mission to fully define the mineralized potential at Montauban. “We are entering a new phase of discovery powered by cutting-edge imaging tools that will allow us to explore below the limits of historic drilling and uncover the full scope of the Montauban system,” Kitchen said. “Our team is excited and looks forward to sharing results with the market before the end of the month.”

In parallel with the imaging work, ESGold is preparing an updated Preliminary Economic Assessment (“PEA”). The new assessment will reflect the current environment of high gold and silver prices, updated resource potential, and revised production timelines. The previous PEA is being updated to incorporate both near-surface and potential deeper mineralization.

With processing results due in the coming weeks, investors will soon have a clearer view of what lies beneath the Montauban site. If the ANT survey confirms large-scale mineralized structures, ESGold may significantly expand its exploration footprint, boosting the longer-term value of the project as it nears production.

For more information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
• AVERSA technology can be incorporated into any transdermal patch.
• The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
• Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
• In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.

Nutriband (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA(TM) technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex(R), a widely used aversive agent, to enhance the deterrent profile of its patch formulation.

AVERSA Fentanyl has the potential to be the first and only abuse-deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse-deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (“ADHD”). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s “Young Entrepreneur of the Year” in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• Social media marketing innovator Thumzup Media is growing at a 243% CAGR as companies across the nation learn of its proprietary platform for effectively connecting retailers and social media users through influencers helping to promote products
• Thumzup Media’s AdTech platform is designed to help companies develop and manage social media campaigns, while making it easy for influencers to collect cash payments via Venmo or PayPal
• Thumzup is speeding its coding and platform innovations through the use of artificial intelligence that makes it fast and simple to develop new programming without the need to employ large teams of code engineers
• Market analysts predict revenue generated by social media commerce will hit the trillion-dollar mark globally within the next three years

As the number of people using social media forums continues to grow, revenue is likewise increasing for products that social media influencers post about to the followers they have accumulated. Marketing innovator and brand booster Thumzup (NASDAQ: TZUP) is providing infrastructure to the wild frontier of social media advertising while further democratizing the interaction between retailers and the influencers helping to get the word out about companies’ products.

Thumzup has increased the number of clients purchasing its proprietary AdTech platform at a CAGR of 243% over the past year with expectations of crossing the 1,000-client threshold by mid-Q2. “Surpassing 800 advertisers (as of April 1) is a testament to the increasing adoption of our platform,” Thumzup CEO Robert Steele stated in a recent news release (https://ibn.fm/lfJbc). “Our strategic investments and market accelerations are driving significant value and positioning us for continued growth. We are looking forward to continuing this growth trajectory.”

The AdTech platform and accompanying app (available at the App Store and Google Play) are key innovations that have helped drive Thumzup’s growth, making it easier for companies to build and administer social media campaigns and for influencers to obtain cash payments as remuneration for their efforts. The company’s strategy builds on the innovations of Uber in a sense, adapting the ridesharing model to the advertising market. Recent platform enhancements allowing video capabilities have made it easier for advertisers to tap into the growing popularity of short-form video content through Instagram Reels, thereby expanding the potential of their campaigns.

In addition, Thumzup has adopted advanced artificial intelligence (“AI”) tools into its software development process, making the code-writing and debugging process move faster and more efficiently so that platform creation and adaptability can move much more quickly. “By using tools like GitHub Copilot and Claude AI by Anthropic, our team can focus on creativity and innovation, ensuring that the Thumzup app continues to evolve with cutting-edge features that meet the needs of our users and brand partners,” Steele stated (https://ibn.fm/EzDq7). “This move not only accelerates our time to market but will also reduce the development costs of writing code, reinforcing our mission to revolutionize how people connect with businesses through social media.”

The adoption of AI code-writing capabilities to speed growth and lower development costs is a growing trend among tech startups, highlighted in a recent news article on the subject (https://ibn.fm/oF5wg). Market analysts at the Statista agency are forecasting revenue generated by social commerce will hit the trillion-dollar mark globally within the next three years, underscoring the importance of Thumzup’s ability to keep its development pace competitive and accessible (https://ibn.fm/ex8Pi).

For more information, including insights from the company’s recent shareholder letter, visit the company’s website at www.ThumzupMedia.com.

NOTE TO INVESTORS: The latest news and updates relating to TZUP are available in the company’s newsroom at https://ibn.fm/TZUP

• Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of patients
• Nutriband recently announced two significant partnerships poised to expand its manufacturing capabilities and market reach
• These partnerships, along with the company’s already existing alliances, align with Nutriband’s core mission of developing transdermal pharmaceutical products

Strategic alliances are vital to success in the pharmaceutical sector, where innovation, regulatory navigation and market access are complex and resource-intensive. Collaborations between biotech firms, research institutions and major pharmaceutical companies accelerate drug development, reduce costs and enhance the likelihood of regulatory approval. Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, has recently announced a series of strategic partnerships and alliances designed to strengthen its foothold in the growing pharmacy space.

“The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic alliances,” stated a recent Pharma Contract report (https://ibn.fm/LkGF7). Titled “The Evolution of Strategic Partnerships in the Pharmaceutical Industry,” the article noted that “this shift isn’t just about adapting to market pressures — it’s about embracing opportunities to foster innovation, streamline processes and ultimately improve the lives of patients. With this in play, it’s important to understand the benefits gained from effective partnerships and the essential ingredients for building meaningful, lasting partnerships.”

The article went on to note that strategic partnerships can create significant value, including benefiting from shared expertise, accessibility to new markets and patient-centric approaches. “While strategic partnerships are an effective way forward for the industry, the path forward needs to be forged using a good understanding of the building blocks of successful collaboration,” the article stated. “This entails going beyond the ‘usual’ business agreements and stepping foot into the ‘zone of added value.’ This zone represents a shared vision for innovation, fostering a positive work culture and resource optimization, which can all help achieve improved patient outcomes.”

Nutriband clearly understands the power of strategic alliances in the growing pharmaceutical industry. The company recently announced two significant partnerships that are poised to expand its manufacturing capabilities and market reach. These collaborations underscore Nutriband’s deliberate efforts to leverage its proprietary technologies and manufacturing expertise in the health and wellness sector.

Earlier this month, Nutriband signed an associate partnership agreement with Charlotte FC (https://ibn.fm/Eie9l). According to the announcement, Nutriband plans to leverage the associate partnership to build visibility for its brands, including AI Tape, which is manufactured in the Charlotte area at Nutriband’s Pocono Pharmaceutical facility. “We are very excited to partner with an organization such as Charlotte FC,” the company stated. “Manufacturing many of our products locally in the Charlotte region through our Pocono subsidiary makes this relationship special.”

Nutriband also noted that it plans to use the Charlotte FC relationship to promote AVERSA(TM), its proprietary platform technology. The company believes that AVERSA has the potential to be the world’s first and only abuse deterrent patch platform for managing chronic pain.

In connection with AVERSA, Nutriband announced earlier this year that it had signed an addendum to the Commercial Development and Clinical Supply Agreement for its lead product, Aversa(TM) Fentanyl. The agreement is with partner Kindeva Drug Delivery (https://ibn.fm/x2FWf), a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products.

Nutriband is partnering with Kindeva Drug Delivery to develop Aversa Fentanyl, which combines Nutriband’s AVERSA(TM) abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. Nutriband and Kindeva have revised their agreement to formalize their exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments.

These partnerships, along with the company’s already existing alliances, align with Nutriband’s core mission of developing transdermal pharmaceutical products. By collaborating with established brands in the health and wellness industry, Nutriband aims to diversify its revenue streams and reinforce its position as a leader in transdermal drug delivery solutions.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• Torr Metals operates in well-endowed mining regions, surrounded by major players like Teck’s Highland Valley Copper and Copper Mountain Mining
• Projects are strategically located near major highways and existing infrastructure, reducing exploration costs and improving logistics
• Recently announced Kolos expansion with optioning of drill-permitted Bertha Property, per latest press release
• Nine new geophysical anomalies discovered at Filion Project

Leveraging Established Mining Districts for Growth

Torr Metals (TSX-V: TMET) has set itself apart in the junior mining sector by strategically positioning its projects within prolific mining districts. By surrounding itself with major industry players and existing infrastructure, the company maximizes its chances of exploration success while minimizing logistical challenges and costs, as CEO Malcolm Dorsey recently explained in an interview: (ibn.fm/SdV3J).

A Prime Location in BC’s Mining Hub

The Kolos copper-gold project is situated in the Quesnel Trough of southern British Columbia, an area known for hosting world-class porphyry deposits. The project is adjacent to Highway 5 and located near Teck Resources’ Highland Valley Copper Mine (30 km west), Copper Mountain Mine (100 km south), and New Gold’s New Afton Mine (30 km north). This deposit places Kolos in the heart of a proven mineralized corridor.

Torr Metals acquired the Kolos project and has since conducted extensive fieldwork. Looking at data from historical prospecting, management was encouraged by economical grades of 0.5% copper and 4 g/t gold in outcrop. Systematic soil sampling further delineated three porphyry targets, spanning a seven-kilometer trend, with copper values reaching 1,200 ppm and gold values exceeding 700 ppb. Additionally, geophysical surveys indicate mineralization could be at depth, with potential targets extending over 1.5 kilometers below the surface. The systems are nearly 2 kilometers wide in the subsystem.

2025: A Year of Potential Catalysts

Looking ahead, Torr Metals expects to secure drill permits for Kolos in the near term, positioning the company to launch its maiden drill program. If successful, drilling could significantly de-risk the project and attract further investor interest. 

As the new year unfolds, TMET recently announced the expansion of its Kolos project by acquiring the Bertha Property through an option agreement (ibn.fm/nZnJO). The Bertha Property, which is drill-permitted and has historical high-grade copper findings up to 8.48%, significantly enhances Kolo’s potential. This acquisition adds several new copper and gold occurrences with both porphyry and epithermal potential, ultimately aiming for a targeted drill program in 2025. The expansion also increases the project’s coverage to 332 km², situated in a prolific mining district in southern British Columbia.

Filion Gold Project: A Strategic Ontario Asset

In northern Ontario, Torr Metals is advancing its Filion Gold project, located within the Archean Greenstone Belt—a region renowned for multi-million-ounce gold deposits. Nearby mines include the Greenstone Gold Mine to the west, Detour Lake to the northeast, and Casa Berardi to the east. Similar to Kolos, Filion benefits from excellent infrastructure, as it is adjacent to the Trans-Canada Highway.

Historical sampling at Filion identified high-grade gold mineralization, including values of 91 g/t gold and 9 g/t gold over a three-kilometer strike length. Recent soil testing of more than 1,100 samples has defined a 1,200-meter-long gold anomaly, with additional parallel structures emerging from expanded surveys. The company’s goal is to further delineate these targets and assess their drill readiness.

The Latest Development: High-Resistivity Anomalies & Drill Targets

As detailed on February 19, Torr has identified nine high-resistivity geophysical anomalies at Filion through magnetic and VLF-EM surveys. These anomalies highlight structural controls on gold mineralization and reveal new exploration targets.

The largest anomaly, spanning 3.3 kilometers, hosts the Oscar gold occurrence, with historical grab samples showing up to 9.1 g/t gold. Nearby, Miller East reported 91.4 g/t gold over 0.3 meters. The correlation with iron formations and shear structures indicates strong drill potential.

The VLF-EM survey also identified two gold-bearing trends:

• Zones A, B, C: Shear structures aligned with felsic intrusions, showing gold anomalies and alteration.
• Zone D: The Oscar occurrence, with magnetic and resistivity signatures suggesting gold-bearing altered iron formations.

Pending geochemical results from late-2024 soil sampling will provide further insights into untested shear structures, covering 80% of West Filion.

For more information, visit the company’s website at www.TorrMetals.com

NOTE TO INVESTORS: The latest news and updates relating to TMET are available in the company’s newsroom at https://ibn.fm/TMET

• Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to quality care, in profitable shift from fee-for-service to value-based models.
• Its system helps decipher complex insurance contracts to maximize reimbursements.
• The software helps decipher complex insurance contracts to maximize reimbursements, integrating smoothly with major electronic health record systems to identify high-risk patients and care gaps.
• Adageis is continuously working with investors to expand its offerings for a growing list of small and independent practices.

Adageis, a forward-thinking healthcare technology company focused on value-based care solutions, is helping clinics and medical groups measure how their delivery of high-quality care translates into financial return. The company’s AI-driven platform enables providers to visualize revenue trends over time, identify where value-based incentives are being earned, and assess the impact of care improvements on the bottom line.

The ProActive Care platform, recently rebranded as a fintech AI solution, targets a long-standing challenge in healthcare: the complexity of insurance contracts. By clarifying how and when providers are rewarded for meeting care quality benchmarks, Adageis gives healthcare organizations a clearer picture of their performance and profitability.

For many smaller practices and clinics transitioning to value-based care, understanding these metrics can be difficult. Adageis offers tools to track performance in real time, linking patient outcomes with financial rewards. This transparency is especially important in today’s healthcare environment, where incentives increasingly hinge on quality, efficiency, and efficient population health management.

The ProActive Care Platform is central to the company’s offering, incorporating several proprietary components. One is the Value-Based Care Engine, designed to help organizations improve patient outcomes while meeting the standards required to unlock financial bonuses under value-based contracts.

Another core component is the Patented Risk Engine (“PRE”). It uses AI to detect high-risk patients and identify potential care gaps. This enables earlier interventions that can reduce costs over time while improving long-term outcomes. The company’s Proactive Efficiency system goes a step further, monitoring patient health continuously—not just during office visits—giving providers tools to act before conditions worsen.

Adageis also aims to reduce friction in the adoption of its technology. The platform includes a flexible API interface that integrates with widely used EHR systems such as Epic, Cerner, Allscripts, eClinicalWorks, and AthenaHealth. This compatibility allows providers to adopt the software without changing their core systems or workflows.

The company emphasizes its role not just as a software provider but as an advocate for healthcare organizations. Through its analytics and reporting tools, Adageis helps clients better understand what they are owed from insurers and where opportunities exist to improve their revenue position. The goal is to put clinics and medical groups in a stronger negotiating position while also improving care delivery.

Adageis continues to expand its offerings by working with investors interested in supporting small and independent practices. These smaller organizations often face greater financial and operational pressures when transitioning to new care models. By developing targeted solutions, Adageis aims to make value-based care accessible beyond large hospital systems or academic medical centers.

The company’s broader strategy includes influencing not only care delivery but also operational decisions. Its analytics can inform decisions around supply chain efficiency, practice location, and resource allocation, tying financial performance directly to operational choices.

As value-based care becomes more central to healthcare reimbursement, tools that quantify its financial impact will be increasingly important. Adageis positions itself as a key player in this transition, focusing on enabling providers to capture the revenue they’ve earned for delivering high-quality care.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

• The Hoadley Hill Rd project will operate as a community solar installation, feeding clean energy into the local grid, and is expected to power approximately 850 homes.
• Solar Simplified will manage customer acquisition and billing for the community solar effort, and the project may qualify for incentives under New York’s NYSERDA NY-Sun Program.
• To support continued growth, SolarBank has announced up to $19 million USD in equity financing from a single institutional investor.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is moving forward with a new solar power installation in upstate New York as part of its expanding renewable energy portfolio. The company announced plans to develop the 7.2 megawatt Hoadley Hill Rd solar project, to be located on a secured leased site, with interconnection approval already requested (https://ibn.fm/Y4VIZ).

Once operational, the installation is expected to serve as a community solar project, allowing local renters and homeowners to subscribe to the project and receive credits on their electric bills. The model provides households with access to renewable energy without requiring the installation of rooftop panels. According to the company, the Hoadley Hill project is expected to generate enough electricity to power roughly 850 homes.

The project could be eligible for incentives through the New York State Energy Research and Development Authority (“NYSERDA”) NY-Sun Program, which supports the deployment of solar in the state. That approval, along with permitting and financing, will be required before construction can begin.

The customer-facing side of the Hoadley Hill project will be managed by Solar Simplified, a third-party provider specializing in customer enrollment and billing for community solar. By outsourcing customer acquisition and management, SolarBank can focus on engineering, development, and execution of projects while ensuring that capacity is fully subscribed from day one.

The Hoadley Hill project marks another step forward for the company’s strategy to grow its pipeline of renewable energy assets, particularly in the U.S. Northeast and Canada. SolarBank’s current development pipeline now exceeds one gigawatt, including several solar projects and battery energy storage systems (“BESS”), such as two BESS projects underway in Ontario and one in New York.

To fund this and other initiatives, the company recently announced up to $19 million USD in equity financing through a registered direct offering (https://ibn.fm/154Ov). SolarBank entered into an agreement with a single institutional investor to sell 2.39 million common shares and accompanying warrants at a combined purchase price of $3.55 USD per share and warrant, for initial gross proceeds of approximately $8.5 million USD.

Details of the financing indicate the warrants are exercisable at $4.45 USD per share and are valid for five years. If fully exercised, the warrants could raise an additional $10.65 million USD, though the company cautioned there is no guarantee that the warrants will be exercised.

SolarBank plans to use proceeds from the offering to further develop its independent power producer assets, but also for working capital and other corporate needs. The move reflects SolarBank’s broader strategy of expanding its footprint across North America’s clean energy sector, positioning itself to support growing demand for decentralized, renewable power generation.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “7.2 MW Hoadley Hill Rd Solar Project in Development by SolarBank in New York” and “SolarBank Corporation Announces Closing of up to US$19 Million Equity Financing” for additional details on the statements and related assumptions and risks.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• The company has recently announced a new AI capability, delivering tailored recommendations while equipping businesses and influencers with powerful AI-driven tools to capitalize on a dynamic, high-growth market
• Thumzup recently uplisted to the Nasdaq exchange and reported CAGR growth in its list of company clients of 243% during the past year

AI agents are transforming industries around the world and the same could potentially disrupt the marketing sector. Digital marketing innovator Thumzup (NASDAQ: TZUP) is democratizing social media marketing – enabling businesses to choose how much to pay a person (influencer poster) to post about their brand or business to friends or acquaintances on participating social media platforms.

Thumzup is now increasing its ability to help users appeal to consumer interests, introducing a patent-pending AI application named Gibberlink Advertising (TM) to improve consumers’ experiences in making lifestyle shopping choices. Gibberlink Advertising, which will also be known conveniently as GibberAds (TM), is “designed to create demand for unique real-time offers made to Thumzup users by participating advertisers,” according to a company statement issued March 26 (https://ibn.fm/wuyhF).

“Thumzup is looking to provide you with AI agents that are experts in areas like fashion, dining, and even conversation. After capturing your preferences, budget and needs, our AI would work with a network of AI agents to find you the best prices, places and fit for your outings,” a companion video states (https://ibn.fm/3dn0K).

The new service brand envisions AI agents working together to deliver the best experiences based on a defined budget for activities, ranging from a first date to a personal spa getaway, as demonstrated in the GibberAds campaign. The GibberAds service would simultaneously facilitate business competitiveness through responsiveness to consumer interests, empowering social media influencers to wield a cutting-edge tool to appeal to their followers.

“Our Lifestyle AI Agent Marketplace is poised to redefine how people plan experiences and how businesses engage with them,” Thumzup CEO and Board Chairman Robert Steele stated. “This is a multi billion-dollar opportunity and we look forward to continuing to innovate within the space.”

The company’s AI ecosystem will allow influencers to earn commissions for every AI agent download using a unique referral link, while businesses would have access to applicable consumer data.

Thumzup has built its portfolio of company clients through its proprietary AdTech platform, which helps companies build and administer their social media advertising campaigns as they work in tandem with influencers to promote products and services, while the influencers are able to obtain cash payment through a simple forum.

The number of Internet users participating in social media forums has exploded in recent years. Forbes reported last year that 90% of B2B marketers are now using social media to enhance their efforts, finding that the channels can increase generation of inbound demand for a product, shorten the sales cycle, decrease churn and increase benefits for existing customers (https://ibn.fm/bJa45).

Statista market analysts are forecasting revenue generated by social commerce will hit the trillion-dollar mark globally within the next three years (https://ibn.fm/fAiYb). Thumzup has experienced a CAGR of more than 200% during the past year in client acquisition and expects to soon top 1,000 currently participating clients.

For more information, visit the company’s website at www.ThumzupMedia.com.

NOTE TO INVESTORS: The latest news and updates relating to TZUP are available in the company’s newsroom at https://ibn.fm/TZUP

• Quality putters help golfers maintain control and improve accuracy.
• Newton Golf Company is dedicated to delivering superior craftsmanship and ensuring that every putter meets the highest standards of precision and performance.
• The company offers a range of gravity putters designed to suit different playing styles.

In the game of golf, precision and consistency are essential, and nowhere is this more apparent than on the putting green. A well-made putter can mean the difference between shaving strokes off a round or watching an otherwise solid performance unravel on the greens. Among the many advancements in golf technology, Newton Golf’s Gravity putters have emerged as a game-changer. These putters, engineered to optimize balance and stability, help golfers maintain control and improve accuracy, making them an indispensable tool for players aiming to elevate their performance.

Gravity putters use carefully distributed weight and advanced design to enhance a golfer’s feel and control. Known for its patented Ultra-Low Balance Point (“ULBP”) technology, the precise weight distribution promotes a smoother and more consistent stroke, reducing the chances of mishits and ensuring better accuracy. A Gravity putter encourages a more natural pendulum-like motion, allowing the golfer to strike the ball more consistently. For serious golfers, investing in a high-quality Gravity putter can be the key to unlocking greater confidence and lowering their scores.

Newton Golf Company (NASDAQ: NWTG), a rising star in the golf equipment industry, has recognized the importance of Gravity putters and is committed to producing the highest-quality putters available on the market. Made in the U.S.A. at Newton Golf’s facility in St. Joseph, Missouri, the company is dedicated to delivering superior craftsmanship and ensuring that every putter meets the highest standards of precision and performance. Newton Golf leverages cutting-edge technology and a deep understanding of golf mechanics to create putters that provide players with exceptional feel, balance, and consistency.

The Gravity putters from Newton Golf Co. are designed with meticulous attention to detail. Each putter is carefully crafted using premium materials and advanced manufacturing techniques, resulting in a putter that not only looks exceptional but performs flawlessly on the course. Newton Golf’s commitment to quality extends beyond aesthetics — these putters are engineered to provide players with the control and confidence they need to excel in their short game.

Newton Golf understands that every golfer has a unique style and preference, which is why the company offers a range of Gravity putters designed to suit different playing styles. Whether a golfer prefers a mallet-style putter for added stability or a blade putter for a more traditional feel, Newton Golf has options that deliver the perfect balance and control. The company’s Gravity putters are designed to enhance a player’s ability to read greens, control speed, and sink more putts with confidence.

In addition to delivering high-quality equipment, Newton Golf takes pride in its commitment to innovation and improvement. The company continuously evaluates its designs and incorporates feedback from professional golfers and everyday players. This dedication to refining its products ensures that Newton Golf Co. remains at the forefront of golf technology, offering players the most effective tools to enhance their performance.

As golfers seek to refine their game and improve putting accuracy, the importance of a reliable, high-quality gravity putter cannot be overstated. Investing in a putter from Newton Golf Co. provides golfers with an edge on the greens, allowing them to putt with more confidence and precision. With a focus on excellence and a passion for improving the game, Newton Golf Co. has positioned itself as a leading manufacturer of Gravity putters that deliver unmatched performance.

For more information, visit www.NewtonGolfCo.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG